Filter AI tools by vendor, specific workflows, and critical features
This directory of AI solutions in healthcare is HealthyData.Science’s curated catalogue of AI tools for healthcare and life sciences teams. It brings together clinical, operational, commercial, and regulatory use cases in one place so leaders can quickly see what’s available and how each tool is positioned across real‑world workflows. This page is designed for roles such as CMIO, CDO, service line leads, heads of clinical development, pharmacovigilance leaders, commercial and market‑access teams, and MedTech product or regulatory leaders who need a neutral starting point for shortlisting and comparing AI options. Tools are organised by high‑level domains (for example, Clinical AI and Diagnostics, Drug Development and Research, Digital Health, Commercial & Market Access, and Regulatory & Compliance), more specific workflows (such as clinical trials, pharmacovigilance, medical imaging, AI agents, or remote patient monitoring), and key features such as clinical trial support, clinical validation, regulatory‑ready design, or EHR integration. All entries are reviewed against public documentation and, where available, evidence from deployments, certifications, and regulatory filings. Listings are based on independent research, and are updated as vendors, regulations, and real‑world experience evolve; sponsored visibility may affect placement but not the substance of the analysis.
HealthyData.Science reviews publicly available information for each tool, including technical documentation, healthcare use cases, evidence summaries, and any disclosed certifications or regulatory clearances. Tools are then profiled using a consistent structure that covers intended use, deployment model, evidence and validation, regulatory status, and known risks or limitations.
No. The tools listed in this directory are intended to support, not replace, the judgment of clinicians, safety professionals, and regulatory or quality teams. Any use in patient‑impacting, GxP, or regulatory workflows should follow local governance processes, with human review and approval remaining mandatory.
Regulatory and evidence information is based on what vendors and regulators make public at the time of review. HealthyData.Science periodically revisits high‑impact tools and categories, but organisations should always confirm the latest regulatory status, indications for use, and validation evidence directly with vendors and relevant authorities before deployment.
This directory is designed as an early‑stage discovery and shortlisting resource, helping teams compare tools by use case, deployment model, and reported evidence. It should be combined with internal requirements gathering, security and privacy assessments, vendor due diligence, and formal procurement and validation processes.
Yes. Vendors and users can submit updates or corrections if information is incomplete or out of date, and HealthyData.Science will review these against available evidence before making changes. This helps keep the directory neutral, accurate, and aligned with real‑world use.
